Abstract
The aim of the study is to introduce into veterinary clinical practice an effective ophthalmic composition under the working name «Altimezaton» with fibrinolytic and mydriatic properties; to establish its effectiveness in the lysis of blood clots in the anterior chamber of the eye, as well as the prevention and treatment of synechiae after blunt trauma of the eye with the occurrence of posttraumatic hyphema; to work out a method of introducing this composition into the anterior chamber of the eye.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
